13F-HR filed by Camber Capital Management LP
Camber Capital Management LP filed this 13F-HR for the quarter ended 2017-09-30, filed 2017-11-14, with 24 holding rows worth $1,577,880,000.
- Accession
- 0001654954-17-010544
- Filer
- CIK 1444043
- Filed
- 2017-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2017
A holdings report, 24 entries on the cover page, a total value of $1,577,880,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,577,880,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 1,500,000 | $376,845,000 | thousands by filing date | put |
| NEKTAR THERAPEUTICS | 640268108 | COM | 5,200,000 | $124,800,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 5,750,000 | $94,473,000 | thousands by filing date | |
| MYLAN NV | N59465109 | SHS EURO | 2,700,000 | $84,699,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 975,000 | $82,534,000 | thousands by filing date | |
| GENOMIC HEALTH, INC. | 37244C101 | COM | 2,458,100 | $78,880,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 2,000,000 | $72,360,000 | thousands by filing date | |
| ENVISION HEALTHCARE CORP | 29414D100 | COM | 1,500,000 | $67,425,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 1,375,000 | $64,969,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 800,000 | $63,672,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,400,000 | $63,504,000 | thousands by filing date | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 5,400,000 | $57,240,000 | thousands by filing date | |
| BIOVERATIV INC | 09075E100 | COM | 1,000,000 | $57,070,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 400,000 | $51,640,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 2,650,000 | $48,893,000 | thousands by filing date | |
| RADIUS HEALTH INC | 750469207 | COM NEW | 1,150,000 | $44,333,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 500,000 | $40,510,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266S106 | COM | 8,000,000 | $35,680,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 2,398,123 | $22,470,000 | thousands by filing date | |
| BIOSCRIP INC | 09069N108 | COM | 6,300,200 | $17,326,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 200,000 | $16,480,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 535,500 | $8,863,000 | thousands by filing date | |
| BIOLASE INC | 090911108 | COMMON STOCK | 5,332,394 | $3,214,000 | thousands by filing date | |
| BIOLASE INC | 090911108 | COMMON STOCK | 1,841,173 | $0 | thousands by filing date | callValue filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001654954-17-010544 | this filing | 2017-11-14 | acceptance time not in the bulk data set |